TG Therapeutics Inc
(FRA:NKB2)
€
15.684
0.162 (1.04%)
Market Cap: 2.54 Bil
Enterprise Value: 2.45 Bil
PE Ratio: 80.14
PB Ratio: 17.02
GF Score: 73/100 - Q1 2024 TG Therapeutics Inc Earnings Call TranscriptMay 01, 2024Earnings
- Q4 2023 TG Therapeutics Inc Earnings Call TranscriptFeb 28, 2024€16.3 (+26.22%)Earnings
- TG Therapeutics Inc at JPMorgan Healthcare Conference TranscriptJan 10, 2024
- Q3 2023 TG Therapeutics Inc Earnings Call TranscriptNov 01, 2023€9.66 (+48.52%)Earnings
- Q2 2023 TG Therapeutics Inc Earnings Call TranscriptAug 01, 2023€9.92 (-44.80%)Earnings
- TG Therapeutics Inc at Jefferies Healthcare Conference TranscriptJun 07, 2023
- TG Therapeutics Inc at Bank of America Global Healthcare Conference TranscriptMay 09, 2023
- Q1 2023 TG Therapeutics Inc Earnings Call TranscriptMay 01, 2023Earnings
- Q4 2022 TG Therapeutics Inc Earnings Call TranscriptFeb 28, 2023Earnings
- TG Therapeutics Inc at JPMorgan Healthcare Conference TranscriptJan 09, 2023
- TG Therapeutics Inc BRIUMVI Call TranscriptDec 29, 2022
- Q3 2022 TG Therapeutics Inc Earnings Call TranscriptNov 10, 2022€7.42 (+35.40%)Earnings
- Q2 2022 TG Therapeutics Inc Earnings Call TranscriptAug 08, 2022€6.03 (-3.08%)Earnings
- TG Therapeutics Inc at B Riley Neuro & Ophthalmology Conference (Virtual) TranscriptApr 28, 2022
- TG Therapeutics Inc Update Call TranscriptApr 18, 2022
- Q4 2021 TG Therapeutics Inc Earnings Call TranscriptMar 01, 2022€9.01 (+5.19%)Earnings
- TG Therapeutics Inc at JPMorgan Healthcare Conference (Virtual) TranscriptJan 10, 2022
- TG Therapeutics Inc Regulatory Updates TranscriptNov 30, 2021
- TG Therapeutics Inc at B Riley Fall Growth Biotech Best Ideas Series (Virtual) TranscriptNov 11, 2021
- Q3 2021 TG Therapeutics Inc Earnings Call TranscriptNov 04, 2021€29.84 (+6.84%)Earnings
- TG Therapeutics Inc ECTRIMS Investor & Analyst Event TranscriptOct 14, 2021
- TG Therapeutics Inc at Cantor Fitzgerald Global Healthcare Conference (Virtual) TranscriptSep 27, 2021
- TG Therapeutics Inc to Discuss Phase 1 U2 + Venetoclax Data Call TranscriptSep 20, 2021
- TG Therapeutics Inc at H C Wainwright Global Investment Conference (Virtual) TranscriptSep 13, 2021
- Q2 2021 TG Therapeutics Inc Earnings Call TranscriptAug 02, 2021€22.69 (-23.88%)Earnings
- TG Therapeutics Inc at Ladenburg Thalmann Virtual Healthcare Conference TranscriptJul 14, 2021
- TG Therapeutics Inc at Raymond James Human Health Innovation Conference (Virtual) TranscriptJun 22, 2021
- TG Therapeutics Inc at Goldman Sachs Global Healthcare Conference (Virtual) TranscriptJun 08, 2021
- Q1 2021 TG Therapeutics Inc Earnings Call TranscriptMay 10, 2021€31.68 (-3.97%)Earnings
- TG Therapeutics Inc ULTIMATE I & II Phase 3 Investor & Analyst Webcast TranscriptApr 16, 2021
- Q4 2020 TG Therapeutics Inc Earnings Call TranscriptMar 02, 2021€37.29 (+0.47%)Earnings
- TG Therapeutics Inc Announces UKONIQ (umbralisib) FDA Approval Conference Call TranscriptFeb 08, 2021
- TG Therapeutics Inc at JPMorgan Healthcare Conference (Virtual) TranscriptJan 12, 2021
- TG Therapeutics Inc Announces Positive Topline Results from the ULTIMATE I & II Phase 3 Studies Conference Call TranscriptDec 10, 2020
- TG Therapeutics Inc at Jefferies Virtual London Healthcare Conference TranscriptNov 17, 2020
- TG Therapeutics Inc ASH Abstract Release Conference Call TranscriptNov 05, 2020
- Q2 2020 TG Therapeutics Inc Earnings Call TranscriptAug 10, 2020€16.22 (-6.80%)Earnings
- TG Therapeutics Inc Annual Shareholders Meeting TranscriptJun 18, 2020
- TG Therapeutics Inc at Goldman Sachs Global Healthcare Conference (Virtual) TranscriptJun 11, 2020
- TG Therapeutics Inc to Discuss UNITY-CLL Phase 3 Trial Conference Call TranscriptMay 05, 2020
- Q4 2019 TG Therapeutics Inc Earnings Call TranscriptMar 03, 2020€12.01 (+0.38%)Earnings
- TG Therapeutics Inc at JPMorgan Healthcare Conference TranscriptJan 16, 2020
- TG Therapeutics, Inc. - Shareholder/Analyst Call TranscriptDec 10, 2019
- Q3 2019 TG Therapeutics Inc Earnings Call TranscriptNov 12, 2019€6.93 (-4.15%)Earnings
- TG Therapeutics, Inc. - Special Call TranscriptOct 28, 2019
- Q2 2019 TG Therapeutics Inc Earnings Call TranscriptAug 09, 2019€6 (+2.74%)Earnings
- Q1 2019 TG Therapeutics Inc Earnings Call TranscriptMay 10, 2019€7.06 (-0.70%)Earnings
- TG Therapeutics, Inc. - Special Call TranscriptApr 01, 2019
- TG Therapeutics, Inc. - Special Call TranscriptFeb 28, 2019
TG Therapeutics Inc at Goldman Sachs Global Healthcare Conference (Virtual) Transcript
Jun 08, 2021 / 05:20PM GMT
Release Date Price:
€30.37
(+4.33%)
Graig Suvannavejh
Goldman Sachs Group, Inc., Research Division - Executive Director & Senior Equity Research Analyst
Hi. Good afternoon, everyone, and welcome to the 120 session of the 42nd Annual Goldman Sachs Global Healthcare Conference. My name is Graig Suvannavejh. I cover both U.S. and European biopharma companies here at Goldman Sachs. It's my great pleasure to be hosting TG Therapeutics today in a fireside chat. And with that, let me welcome Company's CEO, Michael Weiss. Michael, how are you? Thanks for joining us.
Michael S. Weiss
TG Therapeutics, Inc. - Executive Chairman, CEO & President
Thanks for having me, appreciate it.
Graig Suvannavejh
Goldman Sachs Group, Inc., Research Division - Executive Director & Senior Equity Research Analyst
It's actually your second healthcare conference with us. And for those of you who may have joined last year, Michael, you may remember as well, we did our fireside chat. It was the very last day of the conference in the very last time slot. I was happy to
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent ![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust_rating.png)
4.6 out of 5
Trustpilot
![](https://static.gurufocus.com/trust.png)